BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6140426)

  • 1. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
    O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM
    Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga toxin--an expanding role in the pathogenesis of infectious diseases.
    Cantey JR
    J Infect Dis; 1985 May; 151(5):766-71. PubMed ID: 3886803
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins.
    Kongmuang U; Honda T; Miwatani T
    J Clin Microbiol; 1987 Jan; 25(1):115-8. PubMed ID: 3539985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between production of cytotoxin and clinical features in shigellosis.
    Prado D; Cleary TG; Pickering LK; Ericsson CD; Bartlett AV; DuPont HL; Johnson PC
    J Infect Dis; 1986 Jul; 154(1):149-55. PubMed ID: 3519788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae.
    Okuda J; Kurazono H; Takeda Y
    Microb Pathog; 1995 Mar; 18(3):167-72. PubMed ID: 7565011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-O1 Vibrio cholerae produces two newly identified toxins related to Vibrio parahaemolyticus haemolysin and Escherichia coli heat-stable enterotoxin.
    Honda T; Arita M; Takeda T; Yoh M; Miwatani T
    Lancet; 1985 Jul; 2(8447):163-4. PubMed ID: 2862364
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxin profiles of Vibrio cholerae non-O1 from environmental sources in Calcutta, India.
    Nair GB; Oku Y; Takeda Y; Ghosh A; Ghosh RK; Chattopadhyay S; Pal SC; Kaper JB; Takeda T
    Appl Environ Microbiol; 1988 Dec; 54(12):3180-2. PubMed ID: 3223774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ
    Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927
    [No Abstract]   [Full Text] [Related]  

  • 11. From the National Institute of Allergy and Infectious Diseases. Summary of the 25th United States-Japan Joint Conference on cholera and related diarrheal diseases.
    Spriggs DR; Sack RB
    J Infect Dis; 1990 Sep; 162(3):584-90. PubMed ID: 2201739
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1.
    Saha PK; Koley H; Nair GB
    Infect Immun; 1996 Aug; 64(8):3101-8. PubMed ID: 8757840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus acidophilus attenuates toxin production by Vibrio cholerae and shigella dysenteriae following intestinal epithelial cells infection.
    Alamdary SZ; Bakhshi B
    Microb Pathog; 2020 Dec; 149():104543. PubMed ID: 33010360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diarrhea, dysentery, cholera, new frontiers?].
    Niel L; Coue JC; Mérouze F
    Med Trop (Mars); 1994; 54(4):375-6. PubMed ID: 7746137
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial diversity during the cholera epidemic in Dakar, Senegal (1995-1996)].
    Sow AI; Cissé MF; Gaye M; Kébé A; Sy OK; Dia NM; Komo A
    Bull Soc Pathol Exot; 1997; 90(3):160-1. PubMed ID: 9410248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.